3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol

C110H131N29O12S2 — CID 159927287

IUPAC3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol
SMILESC1=Cc2c(cccc2-c2nc(N3CCOCC3)nc3c2ncn3C2CCOC2)C1.CCC(C)n1cnc2c(-c3cccc4c3C=NC4)nc(N3CCOCC3)nc21.CCc1nc2c(-c3cccc(O)c3)nc(N3CCOCC3)nc2n1C(C)CC.CS(=O)(=O)N1CCC(n2cnc3c(-c4cccc5c4C=CC5)nc(N4CCOCC4)nc32)CC1.CS(=O)(=O)N1CCN(CCn2cnc3c(-c4cccc(O)c4)nc(N4CCOCC4)nc32)CC1
InChIInChI=1S/C24H28N6O3S.C22H29N7O4S.C22H23N5O2.C21H24N6O.C21H27N5O2/c1-34(31,32)29-10-8-18(9-11-29)30-16-25-22-21(20-7-3-5-17-4-2-6-19(17)20)26-24(27-23(22)30)28-12-14-33-15-13-28;1-34(31,32)29-9-6-26(7-10-29)5-8-28-16-23-20-19(17-3-2-4-18(30)15-17)24-22(25-21(20)28)27-11-13-33-14-12-27;1-3-15-4-2-6-18(17(15)5-1)19-20-21(27(14-23-20)16-7-10-29-13-16)25-22(24-19)26-8-11-28-12-9-26;1-3-14(2)27-13-23-19-18(16-6-4-5-15-11-22-12-17(15)16)24-21(25-20(19)27)26-7-9-28-10-8-26;1-4-14(3)26-17(5-2)22-19-18(15-7-6-8-16(27)13-15)23-21(24-20(19)26)25-9-11-28-12-10-25/h2-3,5-7,16,18H,4,8-15H2,1H3;2-4,15-16,30H,5-14H2,1H3;1-2,4-6,14,16H,3,7-13H2;4-6,12-14H,3,7-11H2,1-2H3;6-8,13-14,27H,4-5,9-12H2,1-3H3
InChIKeyNZEMENVPNUZANC-UHFFFAOYSA-N
MW2115.58 g/mol
LogP12.77
Rot. Bonds22

About 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol

3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol (PubChem CID 159927287) has the molecular formula C110H131N29O12S2 and a molecular weight of 2115.58 g/mol. Its IUPAC name is 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol.

Molecular Properties

Compound Name3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol
PubChem CID159927287
Molecular FormulaC110H131N29O12S2
Molecular Weight2115.58 g/mol
Exact Mass2114.00
IUPAC Name3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol
SMILESC1=Cc2c(cccc2-c2nc(N3CCOCC3)nc3c2ncn3C2CCOC2)C1.CCC(C)n1cnc2c(-c3cccc4c3C=NC4)nc(N3CCOCC3)nc21.CCc1nc2c(-c3cccc(O)c3)nc(N3CCOCC3)nc2n1C(C)CC.CS(=O)(=O)N1CCC(n2cnc3c(-c4cccc5c4C=CC5)nc(N4CCOCC4)nc32)CC1.CS(=O)(=O)N1CCN(CCn2cnc3c(-c4cccc(O)c4)nc(N4CCOCC4)nc32)CC1
InChIInChI=1S/C24H28N6O3S.C22H29N7O4S.C22H23N5O2.C21H24N6O.C21H27N5O2/c1-34(31,32)29-10-8-18(9-11-29)30-16-25-22-21(20-7-3-5-17-4-2-6-19(17)20)26-24(27-23(22)30)28-12-14-33-15-13-28;1-34(31,32)29-9-6-26(7-10-29)5-8-28-16-23-20-19(17-3-2-4-18(30)15-17)24-22(25-21(20)28)27-11-13-33-14-12-27;1-3-15-4-2-6-18(17(15)5-1)19-20-21(27(14-23-20)16-7-10-29-13-16)25-22(24-19)26-8-11-28-12-9-26;1-3-14(2)27-13-23-19-18(16-6-4-5-15-11-22-12-17(15)16)24-21(25-20(19)27)26-7-9-28-10-8-26;1-4-14(3)26-17(5-2)22-19-18(15-7-6-8-16(27)13-15)23-21(24-20(19)26)25-9-11-28-12-10-25/h2-3,5-7,16,18H,4,8-15H2,1H3;2-4,15-16,30H,5-14H2,1H3;1-2,4-6,14,16H,3,7-13H2;4-6,12-14H,3,7-11H2,1-2H3;6-8,13-14,27H,4-5,9-12H2,1-3H3
InChIKeyNZEMENVPNUZANC-UHFFFAOYSA-N
XLogP12.77
TPSA420.40 Ų
H-Bond Donors2
H-Bond Acceptors39
Rotatable Bonds22
Heavy Atoms153
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002115.58
LogP ≤ 512.77
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1039

Analyze 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol?
The IUPAC name of 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol (CID 159927287) is 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol.
What is the SMILES notation for 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol?
The canonical SMILES for 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol is C1=Cc2c(cccc2-c2nc(N3CCOCC3)nc3c2ncn3C2CCOC2)C1.CCC(C)n1cnc2c(-c3cccc4c3C=NC4)nc(N3CCOCC3)nc21.CCc1nc2c(-c3cccc(O)c3)nc(N3CCOCC3)nc2n1C(C)CC.CS(=O)(=O)N1CCC(n2cnc3c(-c4cccc5c4C=CC5)nc(N4CCOCC4)nc32)CC1.CS(=O)(=O)N1CCN(CCn2cnc3c(-c4cccc(O)c4)nc(N4CCOCC4)nc32)CC1.
What is the InChIKey of 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol?
The InChIKey is NZEMENVPNUZANC-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H28N6O3S.C22H29N7O4S.C22H23N5O2.C21H24N6O.C21H27N5O2/c1-34(31,32)29-10-8-18(9-11-29)30-16-25-22-21(20-7-3-5-17-4-2-6-19(17)20)26-24(27-23(22)30)28-12-14-33-15-13-28;1-34(31,32)29-9-6-26(7-10-29)5-8-28-16-23-20-19(17-3-2-4-18(30)15-17)24-22(25-21(20)28)27-11-13-33-14-12-27;1-3-15-4-2-6-18(17(15)5-1)19-20-21(27(14-23-20)16-7-10-29-13-16)25-22(24-19)26-8-11-28-12-9-26;1-3-14(2)27-13-23-19-18(16-6-4-5-15-11-22-12-17(15)16)24-21(25-20(19)27)26-7-9-28-10-8-26;1-4-14(3)26-17(5-2)22-19-18(15-7-6-8-16(27)13-15)23-21(24-20(19)26)25-9-11-28-12-10-25/h2-3,5-7,16,18H,4,8-15H2,1H3;2-4,15-16,30H,5-14H2,1H3;1-2,4-6,14,16H,3,7-13H2;4-6,12-14H,3,7-11H2,1-2H3;6-8,13-14,27H,4-5,9-12H2,1-3H3.
What are the key properties of 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol?
3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol has a molecular weight of 2115.58 g/mol, XLogP of 12.77, 22 rotatable bonds, 2 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(9-butan-2-yl-8-ethyl-2-morpholin-4-ylpurin-6-yl)phenol;4-[9-butan-2-yl-6-(1H-isoindol-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(1-methylsulfonylpiperidin-4-yl)purin-2-yl]morpholine;4-[6-(1H-inden-4-yl)-9-(oxolan-3-yl)purin-2-yl]morpholine;3-[9-[2-(4-methylsulfonylpiperazin-1-yl)ethyl]-2-morpholin-4-ylpurin-6-yl]phenol is sourced from PubChem (CID 159927287), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).